About SH2 domain-containing adapter protein B
SH2 domain-containing adapter protein B (SHB) is a protein
from Homo sapiens identified by UniProt accession
Q15464, 509 residues long.
MolForge cross-references it against 0 known binders and
61 disease associations.
Target properties
| Protein name | SH2 domain-containing adapter protein B |
| UniProt accession | Q15464 |
| Gene | SHB |
| Organism | Homo sapiens |
| Length | 509 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (61)
Diseases linked to this target (Open Targets).
- balding measurement · score 0.35
- platelet count · score 0.32
- FEV/FVC ratio · score 0.32
- brain measurement · score 0.28
- hair colour measurement · score 0.28
- acne · score 0.28
- pulse pressure measurement · score 0.28
- lymphocyte count · score 0.28
- monocyte count · score 0.27
- hair shape measurement · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15464-F1 | alphafold | PREDICTED | 58.74 | — |
Amino-acid sequence (509 residues)
MAKWLNKYFS LGNSKTKSPP QPPRPDYREQ RRRGERPSQP PQAVPQASSA ASASCGPATA SCFSASSGSL PDDSGSTSDL IRAYRAQKER DFEDPYNGPG SSLRKLRAMC RLDYCGGSGE PGGVQRAFSA SSASGAAGCC CASSGAGAAA SSSSSSGSPH LYRSSSERRP ATPAEVRYIS PKHRLIKVES AAGGGAGDPL GGACAGGRTW SPTACGGKKL LNKCAASAAE ESGAGKKDKV TIADDYSDPF DAKNDLKSKA GKGESAGYME PYEAQRIMTE FQRQESVRSQ HKGIQLYDTP YEPEGQSVDS DSESTVSPRL RESKLPQDDD RPADEYDQPW EWNRVTIPAL AAQFNGNEKR QSSPSPSRDR RRQLRAPGGG FKPIKHGSPE FCGILGERVD PAVPLEKQIW YHGAISRGDA ENLLRLCKEC SYLVRNSQTS KHDYSLSLRS NQGFMHMKLA KTKEKYVLGQ NSPPFDSVPE VIHYYTTRKL PIKGAEHLSL LYPVAVRTL
Explore SH2 domain-containing adapter protein B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets